Abstract
Objective
To devise strategies to amend lay and practitioner atopic eczema mindlines ‘collectively reinforced, internalised tacit guidelines’, to improve consultation experiences and self-management practices in primary care.
Design
Co-creation workshops informed by the Co:Create Coproduction Matrix.
Setting
Conference centre in central England and via remote communication.
Participants
Lay people with, and parents of children with, atopic eczema, practitioners, a researcher and a facilitator (n=22).
Results
Eczema mindline amendment needs to address people and parents of children with the condition, practitioners and wider society in parallel. For lay people trust and ‘realness’ of amendment activity was vital and practitioners wanted practical, locally relevant, hints and tips, tailored, ‘no faff’ approaches. To improve consultation experiences and self-management practices, five key, consistent, evidence-based messages need to be instilled into eczema mindlines: (1) eczema is more than just dry skin, (2) eczema does not just go away, (3) moisturisers are for every day, (4) steroid creams are okay when you need them and (5) you know your child’s eczema best.
Conclusion
This co-creation study provides original insights into what eczema knowledge should be mobilised, who needs to have this knowledge, how this should be achieved to amend existing mindlines to improve consultation experiences and self-management practices in primary care.
The remaining challenge is to refine, implement and evaluate the effectiveness of strategies developed to instil the five core messages and erase outdated or inaccurate information.
Keywords: eczema, dermatology, primary care, qualitative research
Strengths and limitations of this study.
First co-creation study to examine strategies to amend lay–practitioner social atopic eczema mindlines.
Diverse lay and practitioner co-creation group.
Only those with an existing interest in eczema joined the co-creation group.
Introduction
Atopic eczema (hereafter eczema) is a common burdensome long-term skin condition1 with a high self-management demand.2 Evidence-based treatment guidance is available, for example, from the National Institute for Health and Clinical Excellence3 and Clinical Knowledge Summaries.4 The mainstay of treatment is use of topical corticosteroids (TCS) at times of flare and regular, consistent application of emollients even when the skin appears healthy; in essence ‘getting control and keeping control’.5 Eczema management is 97% primary care based in the UK.6 Primary care consultations are often unsatisfactory for patients and practitioners alike.7 8 Patients report practitioners with limited knowledge9 and dismissive attitudes.10 Some practitioners describe uncertainity about optimum treatment11; others regard eczema as simple to treat and perceive, no need to change their current treatment ‘recipe’.12 A particular challenge is ensuring safe and appropriate use of TCS. Steroid phobia is common13 and reinforced at many levels12 14 potentially leading to under treatment, unwarranted suffering or treatment escalation15 and wastage of prescribed medication.16 Eczema is a long-term condition, often with a high self-management demand. Long-term condition self-management is a policy imperative.17–19 Definitions of self-management vary20 but involve ongoing efforts to maintain or improve health. Self-management interventions are designed to increase a person’s capacity, confidence and efficacy of to perform the necessary activities.21 Self-management of long-term skin conditions is notoriously challenging.22 Supportive interventions include bespoke programmes23 and educational and psychological interventions.24–26 However, such offerings are not available to all, are costly and impact is inconsistent.23
Knowledge mobilisation (KM) is essentially ‘moving knowledge to where it can be most useful’27; it involves deliberative actions to create, disseminate and operationalise research and other forms of knowledge.28 KM is context specific,29 relational30 and socially constructed.31 One approach to mobilising knowledge is through amending mindlines.12 14 32 Mindlines are ‘collectively reinforced, internalised tacit guidelines’, which underpin clinical decision-making.33 They are built on a multifaceted combination of knowledge sources such as communication with colleagues and opinion leaders in the field and from personal tactic knowledge developed over time.33 Mindlines are founded in the work of Polyani34 and Nonaka and Takeuchi35; these authors recognise that knowledge is not necessarily conscious and explicit, but is in large part tacit and created from technical know-how and unconscious schemata. In practice, this tacit knowledge is a far more influential than formal codified knowledge.
The seminal mindlines paper of Gabbay and le May36 has been cited 945 times to date. An extensive review a decade later37 reveals that little attention has been paid to condition specific mindlines or to a patient equivalent to mindlines, although Gabbay and le May33 intimate their existence that they do not develop this notion. Repeating the review search strategy reveals a continued absence of focus on patient mindlines with the exception of recent ethnographic work by one of the authors of this paper (FC), elucidating lay and practitioner eczema mindlines.12 14 32 These studies advocate improving eczema consultation experiences and self-management practices in primary care through a concerted effort amend eczema mindlines to increase shared knowledge, understanding and decision-making. It is proposed that this may be achieved through parallel lay and practitioner mindline amendment.
Mindline amendment requires collaborative efforts from lay people, that is, people with and parents of children with eczema, practitioners and researchers. Figure 1 illustrates the fundamentals of eczema mindlines and shows the complexity of how knowledge is gained, from which sources and the inter-relationship between lay–practitioner wider society mindlines. In essence, (1) lay people gain knowledge and beliefs from many sources, for example, personal experience, family, friends and wider society, trial and error, online and from practitioners14; and (2) practitioner actions are underpinned by a belief that eczema is simple to treat ‘the recipe does not change’ and that treatment options are limited by prescribing guidance, knowledge is accrued from early education, colleagues, practical experience and patients.12 Further work illuminates the inter-relationship between the two and therefore the need for efforts to amend mindlines to be a shared venture which transcends lay–practitioner boundaries and instils shared and consistent understanding.32
Figure 1.
Lay (left side) and practitioner (right side) eczema mindlines and inter-relationship between the two.
Co-methodologies in healthcare are increasingly considered to be a ‘good thing’. The language of ‘coworking’ remains contested.38 39 There is a multitude of models but it is increasingly considered that coworking should involve lay people and professionals working as equals at every stage of the research process.39 40 Essential questions when planning co-creation include ‘who is participating, in what and for whose benefit’.41
In light of the prevalence of eczema, the high self-management demand, the challenges of primary care consultations and recent developments in understandings of lay and practitioners eczema mindlines,12 14 32 it seems prudent to investigate the way in which co-creation may be used to devise novel approaches to influence these mindlines. The intention is to mobilise relevant, accurate, up to date and contextually appropriate knowledge to support positive primary care consultations and enable people with eczema to self-manage as effectively as possible.
Methods
Aim
To devise strategies to amend lay and practitioner eczema mindlines to improve consultation experiences and self-management practices in primary care.
Objectives
To agree what a good consultation and effective self-management looks like.
-
To identify
What knowledge needs to be mobilised.
Who needs this knowledge.
How should this knowledge be shared.
Design
We employed a co-creation approach informed by the ‘Gold Standard’ Coproduction Matrix.40 which comprises eight principles as summarised in box 1.
Box 1. Eight principles of the Co:Create Coproduction Matrix.
Holistic: Coproduction should happen at every stage.
Resourced: Meaningful and effective coproduction deserves and requires sufficient resource.
Transparent: Coproduction should have a clear and transparent remit that is,: overall aims, limitations, expectations and commitment.
Inclusive: Coproduction should involve a wide range of people (eg, practitioners, customers, future users, the wider community), capturing individual and differing views.
Iterative: Coproduction should be reciprocal, repeated and progressive, always adapting and building uponon what came before.
Positive: Coproduction should be mutually beneficial and an overall positive experience.
Equal: Each participant and their contribution should be valued equally.
Sustainable: Meaningful coproduction should have a genuine sustainable impact on the project.
Setting, co-creators and process
The co-creation group was recruited via a central England Higher Education Institute website with mass sharing via word of mouth and media posts, professional networks and an existing dermatology patient panel. Maximum variation purposive sampling42 was applied in selecting co-creators of different age, gender and ethnicity, with experience of giving or receiving eczema care, ensuring a balance of lay and practitioner participants (n=22). Potential co-creators were sent an information sheet. Those who agreed to take part received a copy of the original mindline publication of Gabbay and le May36 and a copy of the lay and practitioner eczema mindline illustrations together with a brief explanation of how these had been developed and confirmed. The group met for a series of three face-to-face workshops and iterative email exchanges between April 2018 and March 2019. Workshops took place outside usual working hours at an accessible conference centre. The researcher (FC) and facilitator (CL), both of whom are experienced in co-creation, attended all three workshops. Practitioners attended workshop one, lay people with eczema, or who had children with eczema, attended workshop two and the full group attended workshop three. Following each workshop, data were summarised and emailed to group members for discussion and approval. After the third workshop, final refinement of ideas and terminology for key messages was achieved via email.
Although co-creators were nominally either lay or professional there was a degree of overlap, for example, two of the practitioners had children with eczema and one lay person was also a practitioner. Demographic details are summarised in table 1.
Table 1.
Demographic details of the co-creation group
| Role | Gender | Age range |
| Lay person | F | 35–44 |
| Lay person | M | Under 16 |
| Lay person | F | Under 16 |
| Lay person | M | Over 55 |
| Lay person | F | Over 55 |
| Lay person | F | 25–34 |
| Lay person | F | 45–54 |
| Lay person | F | 25–34 |
| Lay person | F | 45–54 |
| Lay person | F | 35–44 |
| Dermatology specialist nurse | F | 45–54 |
| General practitioner | F | 25–34 |
| General practitioner trainee | M | 25–34 |
| Practice nurse | F | 45–54 |
| Medical student | F | 17–24 |
| Pharmacist | M | 25–34 |
| General practitioner trainee | F | 25–34 |
| Primary care nurse | F | 45–54 |
| Pharmacist | M | 45–54 |
| Pharmacy counter assistant | F | 35–44 |
| Facilitator | F | 45–54 |
| Researcher, facilitator and nurse | F | 45–54 |
Data collection
Data collected included: facilitator notes written throughout the session, summaries of individual and group presentation information recorded on flip chart, checked by group members at the time of writing and artefacts, for example, group member notes and products from activities. Details of workshops are summarised in table 2.
Table 2.
Details of co-creation workshops
| Workshop | Attendees | Time | Activity |
| 1 | Practitioners, researcher and facilitator | 2.5 hours |
|
| 2 | Lay people, researcher and facilitator | 3 hours |
|
| 3 | Lay people, practitioners, researcher and facilitator | 1 day |
|
Data analysis
Data collection and analysis were iterative processes.43 The researcher (FC) transcribed data from workshops and reviewed this as whole prior to summarising. FC and CL analysed the data summaries identifying key points and potential areas for mindline amendment as generated by the group. We paid attention to areas of agreement and disagreement between individuals and groups and circulated data summaries to group members for comment, supplementation and modification.
Reflexivity
A reflexive stance was maintained for the duration of the study with particular consideration being given to subjectivity and positioning of the researcher as a nurse with a particular interest in skin health; pre-understandings were consciously set aside.44
Patient and public involvement
Lay people were involved in the development of the research question, planning and delivering the study and disseminating results.
Results
The co-creation group addressed four question. Each is discussed below with explanatory examples from the data.
1. What makes a good eczema consultation in primary care?
Lay group members suggested that a good consultation for them required a practitioner who understood the impact of eczema on their lives and had time to discuss these issues, ‘usually not enough time to talk about the condition, how it effects life, more talking and understanding would be a good consultation’. Honesty about their knowledge was valued even when limited, provided they ‘point us to useful information, the right direction and resources’. In parallel was the need for practitioners to respect individual’s expertise in their own condition, ‘I have an understanding, long-term and understand when I need help and something different’. Group members wanted to see the same practitioner when possible to avoid feeling ‘sick and tired of saying the same story over and over again’. They wanted practitioners to take eczema seriously, think of it as a long-term condition, ‘to help manage ‘long-term’ rather than short-terms solution for flares’. Group members accepted their role in self-management with even the youngest stating the need for ‘taking responsibility and sharing responsibility for condition……… makes you grow up’. While embracing their contribution to long-term eczema control group members wanted to work with practitioners and to ‘come to an understanding, work together, look at self-management…but…be there for support if needed’. They desired a sense of ‘we can manage this, do not want to feel alone’.
For practitioners, a good eczema consultation was characterised by empathy, with two-way dialogue between ‘equals’ to generate shared understanding of eczema and treatment history asking ‘tactful questions’ so that both parties understand and ‘play the same tune, be on the same page’. Consistency in message from practitioners reduced misunderstandings and enhanced patient’s confidence. They spoke of the long-term nature of eczema and the need to be ‘blunt (honest!)’ about the need to ‘explain long-term use of emollients to avoid flares’. Agreeing goals to ‘get control and keep control’ was pivotal, with some advocating the provision of written information including action plans. Strategies to ‘work with patients and motivate them to use emollients’ and ‘emphasising long-term gain’ were promoted. It was important to find the ‘right’ emollient. Being flexible to patient preference and experience was vital, although difficult within the confines of local prescribing guidelines.
2. What should lay people and practitioners start, stop and continue to improve eczema consultations and self-management?
Co-creators identified the aspects of consultations that should be started, stopped and continued from both perspectives. Common threads included the need for a long-term approach to care, being prepared for the consultation, prioritising eczema, shared decision-making and consistent use of topical treatments (see online supplemental information 1 for more detail). Of note was that the group agreed that general practitioners (GPs) were not necessarily the right practitioner to manage eczema and that more attention needs to be given to the role of other professionals, specifically community pharmacists, pharmacy counter assistants, nurses and health visitors.
bmjopen-2019-036520supp001.pdf (220.8KB, pdf)
3. What are the priority areas for lay and practitioner eczema mindline amendment?
Distillation of data collected from the first two workshops and associated email exchanges identified seven key areas for mindline amendment: (1) prioritise eczema, (2) manage eczema as a long-term condition, (3) prepare for each consultation, (4) be consistent with treatment, (5) work together, (6) get the right emollient and (7) use steroids appropriately. The facets of each area for mindline amendment are summarised in table 3. Each area was viewed from both lay and practitioner perspectives.
Table 3.
Priorities for and facets of eczema mindline amendment
| Priorities for mindline amendment | Facets |
| Prioritise eczema | Be attentive, make eczema the primary reason for consultation, offer or go for follow-up. |
| Manage eczema as a long-term condition | Educate, explain, avoid quick fixes, do not expect a cure, ‘get control, keep control’. |
| Prepare for each consultation | Be aware of patient history, offer facts and good explanation, plan what to say, know what you want to achieve. |
| Be consistent with treatment | Be concordant, know products and how to use them, agree realistic regimens, be truthful, do not waste, try over the counter products, understand local formulary. |
| Work together | Listen and question, acknowledge expertise, understand burden of treatment, plan, get control, keep control. |
| Get the right emollient | Be familiar with products, offer choice, agree feasible regimen. |
| Use topical steroids appropriately | Understand risk and benefits, use for flares, use the best product for the optimum time. |
Following a consensus activity, the group prioritised three areas for mindline amendment: (1) manage eczema as a long-term condition, (2) work together and (3) use topical steroids appropriately.
4. How may lay and practitioner eczema mindlines best be amended?
The group highlighted challenges in modifying mindlines. These included the belief that eczema is not a priority for practitioners, some beliefs are deeply entrenched, and some reluctance to engage in shared decision-making. In essence amendment activities suggested were multifaceted. As each idea was proposed, pros and cons were identified and many discounted as not feasible for reasons such as lack of resources, for example, time and funding.
All agreed that interventions to amend the mindlines of either group in isolation would not be effective as they are inextricably linked. Co-creators identified the influence of wider social influences on beliefs about eczema care, for example, in promulgating powerful messages, such as children ‘grow out of eczema’ and the myth that topical steroid preparations are necessarily ‘dangerous’. For this reason, they suggested that any attempt to amend mindlines would have to address all key players in parallel. For lay people trust and ‘realness’ of amendment, activity was vital and practitioners wanted practical, locally relevant, hints and tips, tailored, ‘no faff’ approaches.
While amendment of knowledge was deemed important, the group was unanimous in agreeing that providing information alone is not sufficient. There is also a need to redress power imbalances between patient and practitioner and promote shared understanding and decision-making. With this in mind, email exchanges with co-creators resulted in the three priorities being translated into five key, consistent, evidence-based messages: (1) eczema is more than just dry skin, (2) eczema does not just go away, (3) moisturisers are for every day, (4) steroid creams are okay when you need them and (5) you know your child’s eczema best. The latter was added as it was considered that initial mindline amendment activity should be targeted and, given the prevalence of childhood eczema, this was a reasonable focus. It also acknowledges the importance of parents’ knowledge and expertise. Each priority is underpinned by a set of simple, illustrated messages (online supplemental information 2). Given the need for consistency, clarity and straightforwardness of messages, at this stage we revisited existing evidence-based resources including National Institute for Health and Care Excellence (NICE) guidance,3 clinical knowledge summaries (CKS)4 and also consulted with the National Eczema Society to ensure consistency and fit with existing evidence base.
bmjopen-2019-036520supp002.pdf (6MB, pdf)
Co-creators worked with a range of resources to develop potential methods of amending lay and practitioner eczema mindlines; initial ideas for further development are summarised in box 2.
Box 2. Initial ideas for mindline amendment strategies.
Holding ‘pop ups’ of eczema information in places not currently targeted.
Having simple information available in skin care sections of supermarkets.
Targeting information at ‘Health Living Pharmacies’.
Using ‘Steroid Sam the emoji’ in information to illustrate topical steroids in a more positive light.
Making more use of the Patient Oriented Eczema Measure/Children’s Dermatology Life Quality Index so parents can be more confident in ‘proving’ impact of eczema during consultations.
Offering a ‘recipe’ for better skin.
Build on existing resources, for example, Dr Ranj’s work.
Discussion
The aim of this co-creation study was to devise strategies to amend lay and practitioner eczema mindlines to improve consultation experiences and self-management practices in primary care. Amending mindlines offers an entirely new approach to changing eczema care, which goes beyond existing education interventions for patients and parents.23–26 It also addresses the identified challenges of primary care practitioners not prioritising their own eczema education.12 In co-creation, particular emphasis was placed on defining what knowledge needs to be mobilised, who needs this knowledge and how should this knowledge be shared. These questions were answered through a series of structured co-creation workshops and virtual communications.
What knowledge needs to be mobilised? Although most lay people and practitioners know the fundamental ‘ingredients’ of eczema care are TCS and emollients, it is knowledge about the nuanced ‘recipe’ for most effective use that needs to be amended. Alongside this, the long-term nature of eczema and the need for mutual understanding between lay person and practitioner must be understood. Who needs this knowledge? Mindline amendment activity needs to be comprehensive, engaging people and parents of children with the condition, the full gamut of practitioners and people in wider society who may influence eczema care. How should this knowledge be shared? Importantly, knowledge alone is not sufficient to improve consultation experiences and self-management practices. There is a parallel need to change the balance of power in patient–practitioner relationships. These results are reflected in the five key messages to underpin eczema mindline amendment (see above).
This original study is one of the first to investigate how condition specific mindlines may best be amended across lay–practitioner social boundaries. A robust approach to co-creation is demonstrated thorough adherence to the Gold Standards for co-creation.40 In particular, the process was well resourced, the group was diverse in terms of age, gender, ethnicity and expertise and was able to agree mutual aims and objectives and consistently and equally work together to achieve these. The co-creative process was reciprocal and progressive, steadily building on previous work to develop a sustainable approach to eczema mindline amendment. Reporting is in accordance with the consolidated criteria for reporting qualitative research.45
Limitations are twofold, first only those with an interest in eczema were likely to take part, thus neglecting the many people who do not prioritise eczema care. Second, face-to-face co-creative time was limited, but this was mitigated by skilled facilitation, careful planning to ensure best use was made of available time and by using follow-up emails and conversations for clarification and development.
The need to address knowledge deficits, embrace key influencers across lay–practitioner social boundaries and power imbalances led to the development of five key messages together with potential modes of delivery intended to bring about widespread changes in eczema mindlines. These are discussed in relation to the existing literature. Findings from this present study reflect existing research that reports poor consultation experiences, practitioners with limited knowledge and apparent apathy and lack of priority given to eczema management by both some lay people and some practitioners.9–11 This mirrors the state of ‘gloom à deux’ in which patients and practitioners share a perception of hopelessness,46 which is inimical to effective care. As with Gabbay and le May,33 the present study points to the inter-relationship of patient–practitioner mindlines. Our findings are in accordance with and extend the findings of Gabbay and le May33 who suggest that in a consultation two sets of mindlines converge as a single instantiation, which is co-constructed during in the encounter. Our study reveals the need to manage this influence directly if eczema care is to improve, a more definitive call than the hint at social influences on healthcare and actions that subsequently occur.33
To date, little has been written about mindline amendment strategies; however, there are elements of our co-created approaches that are congruent with the existing literature. The need to provide clear, simple, ‘real’ messages from trusted sources to a lay audience beyond those directly affected by eczema, but who may nevertheless influence use of treatments, can be grounded in the literature of social marketing (SM) in healthcare. SM amalgamates concepts from commercial marketing and social sciences; it goes beyond simply imparting knowledge widely and is intended to directly influence healthcare actions.47 SM in healthcare has been used internationally since the mid-1970s48 and is considered a potential strategy to improve public health, for example, in reduction of smoking and obesity.49 It embraces health communication techniques based on mass media. Messages can be mediated through other sources, in our case potentially practitioners and lay influencers. Communication approaches are varied and may include targeted message placement, promotion, dissemination and community outreach.50 While evidence of the effectiveness of SM in healthcare remains sparse,51 it is argued that some elements have the potential to support lay mindline amendment, given the high prevalence of childhood eczema, the aim of changing behaviour and the need to get simple, consistent messages to a diverse range of people who have potential to influence treatment use (eg, grandparents, friends and informal contacts).
Approaches to practitioner mindline amendment need to offer ‘no faff’, locally relevant, tailored hints and tips. This need is driven both by the low priority given to eczema and the increasingly heavy workloads of primary care practitioners.52–55 Previous studies identify what is important to practitioners if messages are to influence their practice. Utility of information is measured by some in terms of relevance x validity÷work required to obtain it.56 Evidence suggests that to influence practice, knowledge must (1) relate to the day-to-day challenge of having to manage this patient, at this time and in this situation,57 (2) be accessible, understandable and enable practitioners to make a ‘good enough’ treatment decision and (3) fit with the particularities of the context.29 58 Knowledge that addresses these points allows practitioners to transform it through contextual adroitness into knowledge-in-practice-in-context, which enables good clinical care.59 Strategies to amend practitioner mindlines that take into account the needs outlined above may include, for example, use of aphorisms, that is, succinct sayings that offer advice and convey concentrated wisdom60 or in a similar vein to ‘actionable nuggets’, snippets of practical and memorable information that can be readily used in everyday practice.61
Although knowledge is essential, changing this facet of mindlines alone will not change eczema care. Power differentials between lay person and practitioner also need to be minimised. In agreement with the existing literature, our study concludes that knowledge is power62 does not hold true in primary care eczema consultations. While practitioners often have access to more clinical information, patients are frequently experts in their own condition.63 In common with the existing literature, our group members agreed that when patients are engaged in healthcare decision-making, outcomes64 and levels of satisfaction65 improve. The core messages for all we designed offer common language66 and are intended to reduce ‘informational inequality’67 and thus improve shared understanding and agreed, realistic plans of care.
Efforts to influence the mindlines of all types of healthcare provider are intended to support consistency of information. This approach also addresses power imbalances by widening the range of practitioners with whom lay people may choose to consult. Power imbalances are most frequently problematic in consultations with doctors, which begs the question whether they are best placed to provide eczema care. Eczema consultations with expert dermatology nurses are known to be highly valued by patients.68–71 However, there are few primary care dermatology nurses in post. There are suggestions that community pharmacists and pharmacy counter assistants, who are often the first point of contact and who can offer advice independent of the pharmacist,72 are not yet being fully used.73–75
Conclusion
This study, as with previous research, emphasises the need to improve eczema primary care consultation experiences and self-management practices. As previously noted, approaches to date have predominantly been provision of educational and psychological interventions or the use of written action plans. The present study offers an alternative approach in mindline amendment in which simple, consistent, evidence-based knowledge is shared across patient–practitioner social boundaries to promote shared understanding and which, importantly, acknowledges role of influential members of the wider community. The challenge now is to take the five key messages, underpinned by hints and tips and convert them into a range of formats that can be shared among relevant parties. The impact of this intervention is intended to be revision or modification of mindlines achieved by adding reliable and useful knowledge and erasing outdated or inaccurate information. Further research is needed to assess what bearing it has on primary care eczema consultation experiences and self-management practices.
Supplementary Material
Acknowledgments
Thanks to all co-creators for their contribution to the group and in reviewing drafts of this manuscript and to Jay Nolan-Latchford for the mindline illustrations.
Footnotes
Contributors: FC conceived and designed the study. FC, TA and CL made substantial contributions to the acquisition, analysis and interpretation of data. FC wrote the draft manuscript. TA and CL revised the draft critically for important intellectual content. FC, TA and CL gave final approval of the version published. FC, TA and CL agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding: FC is funded by a National Institute for Health Research Knowledge Mobilisation Research Fellowship (KMRF-2015-04-004).
Disclaimer: This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Competing interests: None declared.
Patient consent for publication: Not required.
Ethics approval: The study was approved by the Birmingham City University, Health, Education and Life Sciences Faculty Academic Ethics Committee.
Provenance and peer review: Not commissioned; externally peer reviewed.
Data availability statement: Data are available upon reasonable request. The datasets generated and/or analysed during the current study are not publicly available as they are not designed to be reanalysed by others but are available from the corresponding author on reasonable request.
References
- 1.Drucker AM, Wang AR, Li W-Q, et al. The burden of atopic dermatitis: summary of a report for the National eczema association. J Invest Dermatol 2017;137:26–30. 10.1016/j.jid.2016.07.012 [DOI] [PubMed] [Google Scholar]
- 2.Klinnert MD, Booster G, Copeland M, et al. Role of behavioral health in management of pediatric atopic dermatitis. Ann Allergy Asthma Immunol 2018;120:42–8. 10.1016/j.anai.2017.10.023 [DOI] [PubMed] [Google Scholar]
- 3.National Institute for Health and Care Excellence Atopic eczema in under 12s: diagnosis and management Clinical guideline [CG57], 2007. Available: https://www.nice.org.uk/guidance/CG57 [Accessed 17 Dec 19].
- 4.National Institute for Health and Care Excellence Clinical knowledge summary eczema – atopic, 2018. Available: https://cks.nice.org.uk/eczema-atopic [Accessed 17 Dec 19].
- 5.Tang TS, Bieber T, Williams HC. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? J Allergy Clin Immunol 2014;133:1615–25. 10.1016/j.jaci.2013.12.1079 [DOI] [PubMed] [Google Scholar]
- 6.Schofield JG, Grindlay D, Williams H. Skin conditions in the UK: a health care needs assessment. centre of evidence based dermatology. University of Nottingham, 2009. [Google Scholar]
- 7.Ali SF, Muhammad MP. Patient preference regarding their role in clinical decision making process: a systematic review. Inter. Jour. of Nurs. Educ. 2014;6:192–5. 10.5958/0974-9357.2014.00632.1 [DOI] [Google Scholar]
- 8.Horrocks S, Coast J. Patient choice: an exploration of primary care dermatology patients' values and expectations of care. Qual Prim Care 2007;15:185–93. [Google Scholar]
- 9.Santer M, Muller I, Yardley L, et al. Parents' and carers' views about emollients for childhood eczema: qualitative interview study. BMJ Open 2016;6:e011887. 10.1136/bmjopen-2016-011887 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Magin PJ, Adams J, Heading GS, et al. Patients with skin disease and their relationships with their doctors: a qualitative study of patients with acne, psoriasis and eczema. Med J Aust 2009;190:62–4. 10.5694/j.1326-5377.2009.tb02276.x [DOI] [PubMed] [Google Scholar]
- 11.Le Roux E, Powell K, Banks JP, et al. GPs’ experiences of diagnosing and managing childhood eczema: a qualitative study in primary care. Br J Gen Pract 2018:bjgp18X694529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Cowdell F. Knowledge mobilisation: an ethnographic study of the influence of practitioner mindlines on atopic eczema self-management in primary care in the UK. BMJ Open 2019;9:e025220. 10.1136/bmjopen-2018-025220 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hon K-LE, Kam W-YC, Leung T-F, et al. Steroid fears in children with eczema. Acta Paediatr 2006;95:1451–5. 10.1080/08035250600612298 [DOI] [PubMed] [Google Scholar]
- 14.Cowdell F. Knowledge mobilisation: an ethnographic study of the influence of lay mindlines on eczema self-management in primary care in the UK. BMJ Open 2018;8:e021498. 10.1136/bmjopen-2018-021498 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Thomas KS, Stuart B, O'Leary CJ, et al. Validation of treatment escalation as a definition of atopic eczema flares. PLoS One 2015;10:e0124770. 10.1371/journal.pone.0124770 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Smith SD, Hong E, Fearns S, et al. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol 2010;51:168–74. 10.1111/j.1440-0960.2010.00636.x [DOI] [PubMed] [Google Scholar]
- 17.Miller WR, Lasiter S, Bartlett Ellis R, et al. Chronic disease self-management: a hybrid concept analysis. Nurs Outlook 2015;63:154–61. 10.1016/j.outlook.2014.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Taylor SJC, Pinnock H, Epiphaniou E, et al. A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: prisms – practical systematic review of self-management support for long-term conditions. Health Services and Delivery Research 2014;2:1–580. 10.3310/hsdr02530 [DOI] [PubMed] [Google Scholar]
- 19.Department of Health A mandate from the government to NHS England, 2014. Available: https://www.gov.uk/government/publications/nhs-mandate-2014-to-2015 [Accessed 17 Dec 19].
- 20.Lawn S, Schoo A. Supporting self-management of chronic health conditions: common approaches. Patient Educ Couns 2010;80:205–11. 10.1016/j.pec.2009.10.006 [DOI] [PubMed] [Google Scholar]
- 21.Kennedy A, Bower P, Reeves D, et al. Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. BMJ 2013;346:f2882. 10.1136/bmj.f2882 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ersser SJ, Cowdell FC, Latter SM, et al. Self-Management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol 2010;163:1044–9. 10.1111/j.1365-2133.2010.09916.x [DOI] [PubMed] [Google Scholar]
- 23.Ridd MJ, King AJL, Le Roux E, et al. Systematic review of self-management interventions for people with eczema. Br J Dermatol 2017;177:719–34. 10.1111/bjd.15601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ersser SJ, Cowdell F, Latter S, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2014:CD004054. 10.1002/14651858.CD004054.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bass AM, Anderson KL, Feldman SR. Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review. J Clin Med 2015;4:231–42. 10.3390/jcm4020231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pickett K, Loveman E, Kalita N, et al. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness. Health Technol Assess 2015;19:1–176. 10.3310/hta19860 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ward V. Why, whose, what and how? A framework for knowledge mobilisers. Evid Policy 2017;13:477–97. 10.1332/174426416X14634763278725 [DOI] [Google Scholar]
- 28.Powell A, Davies HT, Nutley SM. Facing the challenges of research informed knowledge mobilization: ‘Practising what we preach’? Public Adm 2017:1–17. [Google Scholar]
- 29.Jackson CL, Greenhalgh T. Co-Creation: a new approach to optimising research impact? Med J Aust 2015;203:283–4. 10.5694/mja15.00219 [DOI] [PubMed] [Google Scholar]
- 30.Ferlie E, Crilly T, Jashapara A, et al. Knowledge mobilisation in healthcare: a critical review of health sector and generic management literature. Soc Sci Med 2012;74:1297–304. 10.1016/j.socscimed.2011.11.042 [DOI] [PubMed] [Google Scholar]
- 31.Marshall M, Pagel C, French C, et al. Moving improvement research closer to practice: the Researcher-in-Residence model. BMJ Qual Saf 2014;23:801–5. 10.1136/bmjqs-2013-002779 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Cowdell F. Knowledge mobilisation: an exploratory qualitative interview study to confirm and envision modification of lay and practitioner eczema mindlines to improve consultation experiences and self-management in primary care in the UK. BMJ Open 2019. b;9:e028225. 10.1136/bmjopen-2018-028225 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gabbay J, le May A. Practice-Based evidence for healthcare: clinical mindlines. London: Routledge, 2011. [Google Scholar]
- 34.Polyani M. The tacit dimension. Abingdon: Routledge & Kegan Paul, 1966. [Google Scholar]
- 35.Nonaka I, Takeuchi H. The knowledge creating company. New York: Oxford University Press, 1995. [Google Scholar]
- 36.Gabbay J, le May A. Evidence based guidelines or collectively constructed "mindlines?" Ethnographic study of knowledge management in primary care. BMJ 2004;329:1013. 10.1136/bmj.329.7473.1013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wieringa S, Greenhalgh T. 10 years of mindlines: a systematic review and commentary. Implement Sci 2015;10:45–55. 10.1186/s13012-015-0229-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Flinders M, Wood M, Cunningham M. The politics of co-production: risks, limits and pollution. Evid Policy 2016;12:261–79. 10.1332/174426415X14412037949967 [DOI] [Google Scholar]
- 39.INVOLVE NIHR Co production. Available: http://www.invo.org.uk/current-work/co-production/ [Accessed 17 Dec 19].
- 40.Co:Create The coproduction matrix. Available: https://www.wearecocreate.com/about [Accessed 16 Jun 20].
- 41.Cornwall A. Unpacking 'Participation': models, meanings and practices. Community Dev J 2008;43:269–83. 10.1093/cdj/bsn010 [DOI] [Google Scholar]
- 42.Palinkas LA, Horwitz SM, Green CA, et al. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health 2015;42:533–44. 10.1007/s10488-013-0528-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Tracy SJ. Qualitative research methods: collecting evidence, crafting analysis, communicating impact. John Wiley & Sons, 2019. [Google Scholar]
- 44.Berger R. Now I see it, now I don’t: researcher’s position and reflexivity in qualitative research. Qualitative Research 2015;15:219–34. 10.1177/1468794112468475 [DOI] [Google Scholar]
- 45.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349–57. 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
- 46.Dodd M. Motivational interviewing ideas for peer mentors. Available: https://niatx.net/toolkits/system/IA_MIforPeerMentors.pdf [Accessed 17 Dec 19].
- 47.National Social Marketing Centre What is social marketing? Available: https://www.thensmc.com/content/what-social-marketing-1 [Accessed 17 Dec 19].
- 48.Walsh DC, Rudd RE, Moeykens BA, et al. Social marketing for public health. Health Aff 1993;12:104–19. 10.1377/hlthaff.12.2.104 [DOI] [PubMed] [Google Scholar]
- 49.Cheng H, Kotler P, Lee N. Social marketing for public health: global trends and success stories. Jones & Bartlett Learning, 2011. [Google Scholar]
- 50.Evans WD. How social marketing works in health care. BMJ 2006;332:1207.2–10. 10.1136/bmj.332.7551.1207-a [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Luca NR, Suggs LS. Theory and model use in social marketing health interventions. J Health Commun 2013;18:20–40. 10.1080/10810730.2012.688243 [DOI] [PubMed] [Google Scholar]
- 52.Doran N, Fox F, Rodham K, et al. Lost to the NHS: a mixed methods study of why GPs leave practice early in England. Br J Gen Pract 2016;66:e128–35. 10.3399/bjgp16X683425 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ball J, Maben J, Griffiths P. Practice nursing: what do we know? British Journal of general practice. Available: https://bjgp.org/content/bjgp/65/630/10.full.pdf [Accessed 17 Dec 19]. [DOI] [PMC free article] [PubMed]
- 54.Gregório J, Cavaco AM, Lapão LV. How to best manage time interaction with patients? community pharmacist workload and service provision analysis. Res Social Adm Pharm 2017;13:133–47. 10.1016/j.sapharm.2016.02.008 [DOI] [PubMed] [Google Scholar]
- 55.Institute of Health Visiting 2019 caseload. Available: https://ihv.org.uk/news_tag/caseload/ [Accessed 17 Dec 19].
- 56.Marie Cunningham A, Shirley A. Mindlines in a digital age. Educ Prim Care 2015;26:293–6. 10.1080/14739879.2015.1079010 [DOI] [PubMed] [Google Scholar]
- 57.Launer J. Guidelines and Mindlines. Postgrad Med J 2015;91:663–4. 10.1136/postgradmedj-2015-133766 [DOI] [PubMed] [Google Scholar]
- 58.Lau R, Stevenson F, Ong BN, et al. Achieving change in primary care—causes of the evidence to practice gap: systematic reviews of reviews. Implementation Sci 2015;11:40 10.1186/s13012-016-0396-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Gabbay J, le May A. Mindlines: making sense of evidence in practice. Br J Gen Pract 2016;66:402–3. 10.3399/bjgp16X686221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Levine D, Bleakley A. Maximising medicine through aphorisms. Med Educ 2012;46:153–62. 10.1111/j.1365-2923.2011.04141.x [DOI] [PubMed] [Google Scholar]
- 61.McColl MA, Aiken A, Smith K, et al. Actionable nuggets: knowledge translation tool for the needs of patients with spinal cord injury. Can Fam Physician 2015;61:e240–8. [PMC free article] [PubMed] [Google Scholar]
- 62.Snider A. Francis bacon and the authority of aphorism. Prose Stud 1988;11:60–71. 10.1080/01440358808586338 [DOI] [Google Scholar]
- 63.O'Neill N, Mitchell G, Twycross A. The expert patient. Evid Based Nurs 2016;19:41–2. 10.1136/eb-2016-102325 [DOI] [PubMed] [Google Scholar]
- 64.Shortell SM, Poon BY, Ramsay PP, et al. A multilevel analysis of patient engagement and patient-reported outcomes in primary care practices of accountable care organizations. J Gen Intern Med 2017;32:640–7. 10.1007/s11606-016-3980-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Rieckmann P, Centonze D, Elovaara I, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st century steering group. Mult Scler Relat Disord 2018;19:153–60. 10.1016/j.msard.2017.11.013 [DOI] [PubMed] [Google Scholar]
- 66.Killian L, Coletti M. The Role of Universal Health Literacy Precautions in Minimizing "Medspeak" and Promoting Shared Decision Making. AMA J Ethics 2017;19:296–303. 10.1001/journalofethics.2017.19.3.pfor1-1703 [DOI] [PubMed] [Google Scholar]
- 67.Kashaf MS, McGill E. Does shared decision making in cancer treatment improve quality of life? A systematic literature review. Med Decis Making 2015;35:1037–48. 10.1177/0272989X15598529 [DOI] [PubMed] [Google Scholar]
- 68.Schuttelaar MLA, Vermeulen KM, Drukker N, et al. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol 2010;162:162–70. 10.1111/j.1365-2133.2009.09502.x [DOI] [PubMed] [Google Scholar]
- 69.Cork MJ, Britton J, Butler L, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149:582–9. 10.1046/j.1365-2133.2003.05595.x [DOI] [PubMed] [Google Scholar]
- 70.Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002;146:432–9. 10.1046/j.1365-2133.2002.04603.x [DOI] [PubMed] [Google Scholar]
- 71.Moore E, Williams A, Manias E, et al. Nurse-Led clinics reduce severity of childhood atopic eczema: a review of the literature. Br J Dermatol 2006;155:1242–8. 10.1111/j.1365-2133.2006.07534.x [DOI] [PubMed] [Google Scholar]
- 72.Tucker R, Stewart D. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems. Int J Pharm Pract 2015;23:390–8. 10.1111/ijpp.12179 [DOI] [PubMed] [Google Scholar]
- 73.Carr A, Patel R, Jones M, et al. A pilot study of a community pharmacist intervention to promote the effective use of emollients in childhood eczema. Pharm J 2007;278:17. [Google Scholar]
- 74.Ward PR, Bissell P, Noyce PR. Medicines counter assistants: roles and responsibilities in the sale of deregulated medicines. Int J Pharm Pract 1998;6:207–15. 10.1111/j.2042-7174.1998.tb00939.x [DOI] [Google Scholar]
- 75.Rutter P. Role of community pharmacists in patients’ self-care and self-medication. Integr Pharm Res Prac 2015;4:57 10.2147/IPRP.S70403 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
bmjopen-2019-036520supp001.pdf (220.8KB, pdf)
bmjopen-2019-036520supp002.pdf (6MB, pdf)

